The World Health Organisation (WHO) has updated global guidance on medicines and diagnostic tests to address health challenges, prioritise highly effective therapeutics, and improve affordable access. The two lists focused on cancer and other global health challenges, with an emphasis on effectiv
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp